Hepatic stellate cells require a stiff environment for myofibroblastic differentiation

被引:266
|
作者
Olsen, Abby L. [1 ,5 ]
Bloomer, Steven A. [1 ]
Chan, Erick P. [1 ]
Gaca, Marianna D. A. [1 ]
Georges, Penelope C. [4 ,6 ]
Sackey, Bridget [5 ]
Uemura, Masayuki [1 ]
Janmey, Paul A. [2 ,4 ,5 ,6 ]
Wells, Rebecca G. [1 ,3 ,5 ,6 ]
机构
[1] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Inst Med & Engn, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA
[6] Univ Penn, Sch Engn & Appl Sci, Bioengn Grad Grp, Philadelphia, PA 19104 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2011年 / 301卷 / 01期
基金
美国国家卫生研究院;
关键词
myofibroblast; liver fibrosis; matrix stiffness; transforming growth factor-beta; Matrigel; GROWTH-FACTOR-BETA; INTEGRIN-LINKED KINASE; SMOOTH MUSCLE ACTIN; RAT-LIVER; SUBSTRATE STIFFNESS; ELASTIC-MODULUS; ADHESION; COLLAGEN; MATRIX; PROLIFERATION;
D O I
10.1152/ajpgi.00412.2010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Olsen AL, Bloomer SA, Chan EP, Gaca MDA, Georges PC, Sackey B, Uemura M, Janmey PA, Wells RG. Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am J Physiol Gastrointest Liver Physiol 301: G110-G118, 2011. First published April 28, 2011; doi:10.1152/ajpgi.00412.2010.-The myofibroblastic differentiation of hepatic stellate cells (HSC) is a critical event in liver fibrosis and is part of the final common pathway to cirrhosis in chronic liver disease from all causes. The molecular mechanisms driving HSC differentiation are not fully understood. Because macroscopic tissue stiffening is a feature of fibrotic disease, we hypothesized that mechanical properties of the underlying matrix are a principal determinant of HSC activation. Primary rat HSC were cultured on inert polyacrylamide supports of variable but precisely defined shear modulus (stiffness) coated with different extracellular matrix proteins or poly-L-lysine. HSC differentiation was determined by cell morphology, immunofluorescence staining, and gene expression. HSC became progressively myofibroblastic as substrate stiffness increased on all coating matrices, including Matrigel. The degree rather than speed of HSC activation correlated with substrate stiffness, with cells cultured on supports of intermediate stiffness adopting stable intermediate phenotypes. Quiescent cells on soft supports were able to undergo myofibroblastic differentiation with exposure to stiff supports. Stiffness-dependent differentiation required adhesion to matrix proteins and the generation of mechanical tension. Transforming growth factor-beta treatment enhanced differentiation on stiff supports, but was not required. HSC differentiate to myofibroblasts in vitro primarily as a function of the physical rather than the chemical properties of the substrate. HSC require a mechanically stiff substrate, with adhesion to matrix proteins and the generation of mechanical tension, to differentiate. These findings suggest that alterations in liver stiffness are a key factor driving the progression of fibrosis.
引用
收藏
页码:G110 / G118
页数:9
相关论文
共 50 条
  • [21] Expression of cellular retinol-binding protein-1 during myofibroblastic differentiation in hepatic stellate cells and portal fibroblasts.
    Uchio, K
    Tuchweber, B
    Manabe, N
    Gabbiani, G
    Rosenbaum, J
    Desmouliere, A
    HEPATOLOGY, 2001, 34 (04) : 404A - 404A
  • [22] Metastatic B16 melanoma cells induce myofibroblastic transformation of hepatic stellate cells.
    Olaso, E
    Santisteban, A
    Bidaurrazaga, J
    Rosenbaum, J
    VidalVanaclocha, F
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 3364 - 3364
  • [23] Activation of hepatic stellate cells: Anti-adipogenic differentiation?
    Tsukamoto, H
    ORGAN MICROCIRCULATION: A GATEWAY TO DIAGNOSITC AND THERAPEUTIC INTERVENTIONS, 2005, 13 : 137 - 144
  • [24] INHIBITION OF MYOFIBROBLASTIC TRANSFORMATION OF STELLATE CELLS BY METHYLXANTHINES
    KAWADA, N
    KOBAYASHI, K
    INOUE, M
    HEPATOLOGY, 1995, 22 (04) : 714 - 714
  • [25] Biological effects of C-type natriuretic peptide in human myofibroblastic hepatic stellate cells
    Tao, JC
    Mallat, A
    Gallois, C
    Belmadani, S
    Méry, PF
    Tran-Van Nhieu, J
    Pavoine, C
    Lotersztajn, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) : 23761 - 23769
  • [26] The fibronectin-derived antiadhesive peptides suppress the myofibroblastic conversion of rat hepatic stellate cells
    Kato, R
    Kamiya, S
    Ueki, M
    Yajima, H
    Ishii, T
    Nakamura, H
    Katayama, T
    Fukai, F
    EXPERIMENTAL CELL RESEARCH, 2001, 265 (01) : 54 - 63
  • [27] Norepinephrine and neuropeptide Y promote proliferation and collagen gene expression of hepatic myofibroblastic stellate cells
    Oben, JA
    Yang, SQ
    Lin, HZ
    Ono, M
    Diehl, AM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 302 (04) : 685 - 690
  • [28] Directed differentiation of human induced pluripotent stem cells to hepatic stellate cells
    Vallverdu, Julia
    Martinez Garcia de la Torre, Raquel A.
    Mannaerts, Inge
    Verhulst, Stefaan
    Smout, Ayla
    Coll, Mar
    Arino, Silvia
    Rubio-Tomas, Teresa
    Aguilar-Bravo, Beatriz
    Martinez-Sanchez, Celia
    Blaya, Delia
    Verfaillie, Catherine M.
    van Grunsven, Leo A.
    Sancho-Bru, Pau
    NATURE PROTOCOLS, 2021, 16 (05) : 2542 - 2563
  • [29] Directed differentiation of human induced pluripotent stem cells to hepatic stellate cells
    Julia Vallverdú
    Raquel A. Martínez García de la Torre
    Inge Mannaerts
    Stefaan Verhulst
    Ayla Smout
    Mar Coll
    Silvia Ariño
    Teresa Rubio-Tomás
    Beatriz Aguilar-Bravo
    Celia Martínez-Sánchez
    Delia Blaya
    Catherine M. Verfaillie
    Leo A. van Grunsven
    Pau Sancho-Bru
    Nature Protocols, 2021, 16 : 2542 - 2563
  • [30] Hepatic stellate cells
    Pinzani, M
    SHOCK, 2004, 21 : 83 - 83